Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccination with T cell-defined antigens.

Expert opinion on biological therapy - 1 May 2004

Panelli Monica C, Wang Ena, Monsurrò Vladia, Jin Ping, Zavaglia Katia, Smith Kina, Ngalame Yvonne, Marincola Francesco M

Abstract excerpt

Tumour immunology encompasses a broad array of biological phenomena including interactions between neoplastic cells and the innate and adaptive immune response. Among immune cells, T cells have taken the centre stage because they can be easily demonstrated to specifically recognise autologous cancer cells. As most tumour-associated antigens are intracellular proteins, T cells appear to be the most suitable tool...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to T-Lymphocytes

Share to Vaccination

Source

Identifiers

PMID: 15155161
DOI: 10.1517/14712598.4.5.697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccination with T cell-defined antigens.PMID 15155161Read ↗

T lymphocytes against solid malignancies: winning ways to defeat tumoursSemantic proximity Read ↗

Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.Semantic proximity Read ↗

Tumour immunology, vaccination and escape strategies.Semantic proximity Read ↗

Melanoma antigens recognised by CD8+ and CD4+ T cells.Semantic proximity Read ↗

Identification of T-cell epitopes for cancer immunotherapySemantic proximity Read ↗

Identification of tumour-associated T-cell epitopes for vaccine development.Semantic proximity Read ↗

Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.Semantic proximity Read ↗

The Anticancer Potential of T Cell Receptor-Engineered T Cells.Semantic proximity Read ↗

Cancer Vaccines: Antigen Selection StrategySemantic proximity Read ↗

Genetically modified T cells in cancer therapy: opportunities and challengesSemantic proximity Read ↗

Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy.Semantic proximity Read ↗

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advancesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.